ArticleHuman vaccines & immunotherapeutics2022
A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology.
Edward J Quinlan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it